Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
(Adds quote)WASHINGTON, Oct 7 (Reuters) - Pfizer Inc's new vaccine for children aged five to 11 could be ready as early as November pending approval from federal regulatory health agencies, White House COVID-19 response coordinator Jeffrey Zients...
Read moreWASHINGTON, Oct 7 (Reuters) - Pfizer Inc's new vaccine for children aged five to 11 could be ready as early as November pending approval from federal regulatory health agencies, White House COVID-19 response coordinator Jeffrey Zients said on Thu...
Read more(Adds comments by PAHO directors, case numbers, U.S. donation)BRASILIA, Oct 6 (Reuters) - The number of new COVID-19 infections has been dropping over the past month throughout the Americas, even though only 37% of the people in Latin America and ...
Read moreBRASILIA, Oct 6 (Reuters) - The number of new COVID-19 infections has been dropping over the past month throughout the Americas, even though only 37% of the people in Latin America and the Caribbean have been fully vaccinated, the Pan American He...
Read more
AstraZeneca seeks emergency FDA approval for drug preventing Covid
Read more
(Sharecast News) - AstraZeneca is seeking approval for a new Covid-19 treatment intended to help people who respond poorly to vaccines, the Anglo-Swedish drugs firm said on Tuesday.
Read more* Could offer an alternative advance protection for COVID-19* Addressing people with weakened immune system* Part of monoclonal antibody drug class (Writes through)By Ludwig Burger and Sachin RavikumarOct 5 (Reuters) - AstraZeneca has requested eme...
Read more(Adds details on treatment, background on vaccine)By Ludwig Burger and Sachin RavikumarOct 5 (Reuters) - AstraZeneca has requested emergency use authorisation from U.S. regulators for its new treatment to prevent COVID-19 for people who respond po...
Read more(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Morrisons shares drop on $9.5 billion takeover* Trading platform Plus500 gains on strong forecast* AstraZeneca up on breakthrough designati...
Read moreAstraZeneca breast cancer drug gets breakthrough therapy designation
Read more(Sharecast News) - AstraZeneca said its breast cancer drug Enhertu had been granted breakthrough therapy designation (BTD) in the US.
Read more(New throughout, adds analyst, investor comment)By Lewis Krauskopf and Manojna MaddipatlaOct 1 (Reuters) - Positive clinical trial results for Merck & Co's experimental antiviral COVID-19 pill reverberated through the healthcare sector on Friday, s...
Read more(Adds details and quote)NEW DELHI, Oct 1 (Reuters) - UK nationals visiting India this month will have to undergo mandatory quarantine even if they are fully vaccinated against COVID-19 in retaliation for UK curbs on Indian citizens, a senior gover...
Read more(Adds J&J comment)Oct 1 (Reuters) - The European Union's drug regulator on Friday identified a possible link between rare cases of blood clotting in deep veins with Johnson & Johnson's COVID-19 vaccine and recommended the condition be listed as a ...
Read more(Adds background on side effects)Oct 1 (Reuters) - The European Union's drug regulator on Friday identified a possible link between rare cases of blood clotting in deep veins with Johnson & Johnson's COVID-19 vaccine and recommended the condition ...
Read more
Last checked at